[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz

Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz image

Treatment Options for Relapsed/Refractory DLBCL with Dr. Elif Yilmaz

Adult DLBCL Chapter
event Feb 08, 2024 / 03:00PM - 04:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Elif Yilmaz will discuss treatment options for relapsed/refractory diffuse large B-cell lymphoma patients. This presentation will include some basics of DLBCL, such as statistics, staging, and explanations of what relapse and refractory mean. Dr. Yilmaz will then discuss management options available to those with R/R DLBCL. This will include individual drugs, treatment regimens, investigational products, and supportive care.

Schedule & Agenda

The panelist Kat Richardson
Introduction
3:00 PM
Kat Richardson

Kat introduces the agenda of the event and featured speaker Dr. Elif Yilmaz. 

The panelist Dr. Elif Yilmaz
Presentation
3:05 PM
Dr. Elif Yilmaz

Dr. Yilmaz shares information about treatment options for the relapsed/refractory DLBCL patient community. 

The panelist Audience
Questions and Answers
3:35 PM
Audience

Type your questions in the chat and Dr. Yilmaz will answer them! 

Speakers & Moderators

The panelist Dr. Elif Yilmaz
Dr. Elif Yilmaz

Dr. Elif Yilmaz, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in indolent and aggressive lymphomas, cellular therapies, and bone marrow transplant. Dr. Yilmaz earned her medical degree at Istanbul University in Turkey. She completed a residency in internal medicine at Sinai Hospital of Baltimore and gained advanced training in hematology and medical oncology through fellowships at George Washington University and Georgetown University School of Medicine. Certified by the American Board of Internal Medicine, she joined the UT Southwestern faculty in 2022. Dr. Yilmaz is a member of the American Society of Hematology and the American Society of Clinical Oncology, among other professional organizations. She has delivered several presentations and published several academic articles related to her areas of expertise.

Read Bio
The panelist Kat Richardson
Kat Richardson

Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew. 

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Diffuse Large B Cell Lymphoma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram youtube